A prostate cancer drug believed to have kept the man convicted of the Lockerbie bombing alive for almost three years has finally been given the go-ahead for use on NHS patients in Scotland.
A prostate cancer drug believed to have kept the man convicted of the Lockerbie bombing alive for almost three years has finally been given the go-ahead for use on NHS patients in Scotland.
PRESCRIBED: Abdelbaset Ali Mohmed al Megrahi survived three years.
Custom byline text:
Helen McArdle
Cancer patients and charities yesterday welcomed the decision by the Scottish Medicines Consortium (SMC) to recommend abiraterone, which was used to treat prostate cancer sufferer Abdelbaset Ali Mohmed al Megrahi before he finally succumbed to the disease May.
We moderate all comments on HeraldScotland on either a pre-moderated or post-moderated basis. If you're a relatively new user then your comments will be reviewed before publication and if we know you well then your comments will be subject to moderation only if other users or the moderators believe you've broken the rules, which are available here.
Moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours. Please be patient if your posts are not approved instantly.
